Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 2.

Felip, Enriqueta, Ardizzoni, Andrea, Ciuleanu, Tudor, Cobo, Manuel, Laktionov, Konstantin, Szilasi, Maria, Califano, Raffaele, Carcereny, Enric, Griffiths, Richard, Paz-Ares, Luis, Duchnowska, Renata, Alonso Garcia, Miriam, Isla, Dolores, Jassem, Jacek ORCID: 0000-0002-8875-6747, Appel, Wiebke, Milanowski, Janusz, Van Meerbeeck, Jan P., Wolf, Juergen, Li, Ang, Acevedo, Angelic and Popat, Sanjay ORCID: 0000-0003-2087-4963 (2020). CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations. Eur. J. Cancer, 127. S. 160 - 173. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Popat, Sanjay ORCID: 0000-0003-2087-4963, Ardizzoni, Andrea, Ciuleanu, Tudor, Dols, Manuel Cobo, Laktionov, Konstantin, Szilasi, Maria, Califano, Raffaele, Costa, Enric Carcereny, Griffiths, Richard, Paz-Ares, Luis, Szczylik, Cezary, Jaime, Jesus Corral, Isla, Dolores, Jassem, Jacek, Appel, Wiebke, van Meerbeeck, Jan, Wolf, Juergen, Jiang, Joel, Molife, L. Rhoda and Felip, Enriqueta (2017). Nivolumab in Patients With Previously TreatedMetastatic Squamous Non-Small Cell Lung Cancer (NSCLC): Results of A European Single-Arm, Phase II Trial (CHECKMATE 171) Including Patients Aged >= 70 Years or With Poor Performance Status. Asia-Pac. J. Clin. Oncol., 13. S. 149 - 151. HOBOKEN: WILEY. ISSN 1743-7563

This list was generated on Sat Dec 4 01:28:29 2021 CET.